Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

583 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer.
Renzelli V, Gallo M, Morviducci L, Marino G, Ragni A, Tuveri E, Faggiano A, Mazzilli R, Natalicchio A, Zatelli MC, Montagnani M, Fogli S, Giuffrida D, Argentiero A, Danesi R, D'Oronzo S, Gori S, Franchina T, Russo A, Monami M, Sciacca L, Cinieri S, Colao A, Avogaro A, Di Cianni G, Giorgino F, Silvestris N. Renzelli V, et al. Among authors: avogaro a. Cancers (Basel). 2023 Aug 24;15(17):4237. doi: 10.3390/cancers15174237. Cancers (Basel). 2023. PMID: 37686512 Free PMC article. Review.
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view.
Natalicchio A, Montagnani M, Gallo M, Marrano N, Faggiano A, Zatelli MC, Mazzilli R, Argentiero A, Danesi R, D'Oronzo S, Fogli S, Giuffrida D, Gori S, Ragni A, Renzelli V, Russo A, Franchina T, Tuveri E, Sciacca L, Monami M, Cirino G, Di Cianni G, Colao A, Avogaro A, Cinieri S, Silvestris N, Giorgino F. Natalicchio A, et al. Among authors: avogaro a. ESMO Open. 2023 Jun;8(3):101573. doi: 10.1016/j.esmoop.2023.101573. Epub 2023 May 31. ESMO Open. 2023. PMID: 37263082 Free PMC article. Review.
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group.
Zatelli MC, Faggiano A, Argentiero A, Danesi R, D'Oronzo S, Fogli S, Franchina T, Giorgino F, Marrano N, Giuffrida D, Gori S, Marino G, Mazzilli R, Monami M, Montagnani M, Morviducci L, Natalicchio A, Ragni A, Renzelli V, Russo A, Sciacca L, Tuveri E, Aimaretti G, Avogaro A, Candido R, Di Maio M, Silvestris N, Gallo M. Zatelli MC, et al. Among authors: avogaro a. Cancer Treat Rev. 2024 May;126:102734. doi: 10.1016/j.ctrv.2024.102734. Epub 2024 Apr 3. Cancer Treat Rev. 2024. PMID: 38604051 Free article. Review.
Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study.
Morieri ML, Raz I, Consoli A, Rigato M, Lapolla A, Broglio F, Bonora E, Avogaro A, Fadini GP; DARWIN-FUP network. Morieri ML, et al. Among authors: avogaro a. J Endocrinol Invest. 2023 Jul;46(7):1429-1439. doi: 10.1007/s40618-022-02002-2. Epub 2023 Jan 9. J Endocrinol Invest. 2023. PMID: 36624223 Free PMC article.
Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.
Fadini GP, Bonora BM, Ghiani M, Anichini R, Melchionda E, Fattor B, Fazion S, Meregalli G, Giaccari A, Avogaro A, Consoli A; GLIMPLES study investigators. Fadini GP, et al. Among authors: avogaro a. Diabetes Obes Metab. 2024 Jun;26(6):2390-2400. doi: 10.1111/dom.15554. Epub 2024 Mar 13. Diabetes Obes Metab. 2024. PMID: 38477183
Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study.
Bonora BM, Russo G, Leonetti F, Strazzabosco M, Nollino L, Aimaretti G, Giaccari A, Broglio F, Consoli A, Avogaro A, Fadini GP; GLIMPLES Study Investigators. Bonora BM, et al. Among authors: avogaro a. J Endocrinol Invest. 2024 Feb 18. doi: 10.1007/s40618-024-02309-2. Online ahead of print. J Endocrinol Invest. 2024. PMID: 38369592
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A; DARWIN-Renal Study Investigators. Fadini GP, et al. Among authors: avogaro a. Lancet Reg Health Eur. 2024 Feb 1;38:100847. doi: 10.1016/j.lanepe.2024.100847. eCollection 2024 Mar. Lancet Reg Health Eur. 2024. PMID: 38328413 Free PMC article.
Increased Soluble Interleukin 6 Receptors in Fabry Disease.
Lenzini L, Iori E, Vettore M, Gugelmo G, Radu C, Padoan A, Carraro G, Simioni P, Calò L, Avogaro A, Rossi GP, Vitturi N. Lenzini L, et al. Among authors: avogaro a. J Clin Med. 2023 Dec 29;13(1):218. doi: 10.3390/jcm13010218. J Clin Med. 2023. PMID: 38202225 Free PMC article.
583 results